Harry Fisher – Project Manager – Benchmark’s prices and data empowers clients: from critical mineral contracts to EV battery supply chain investments and government policy.
Copyright 2023 – Finance News Network
Source: Finance News Network
10 May 2024 - Exploring tin's revival: Elementos CEO & MD Joe David discusses market trends and project developments.
Read More27 Oct 2022 - icetana Limited (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses the company's recent deal with Japanese group Macnica and the launch of a new product.
Read More26 Mar 2025 - The pros and cons of lithium and CERENERGY grid storage batteries
Read More02 Feb 2021 - Centuria Industrial REIT (ASX:CIP) Fund Manager, Jesse Curtis talks 1H21 highlights, acquisitions, leasing activity and second half guidance.
Read More03 Dec 2019 - EQT Holdings Limited (ASX:EQT) Managing Director, Mick O'Brien talks FY19 results, market conditions, contribution from recent acquisitions and outlook for 1H20.
Read More05 May 2022 - Elementos Limited (ASX:ELT) Managing Director Joe David discusses factors behind the recent increase in the tin price and outlines Elementos' key project in Oropesa, Spain.
Read More21 Jun 2022 - BluGlass Limited (ASX:BLG) President Jim Haden discusses shipping an alpha product to a customer, and the development roadmap for the company.
Read More27 Aug 2021 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes provides an update on sales and distribution for the company's Automated Plate Assessment System (APAS), which is used to read culture plates in laboratories.
Read More29 May 2023 - Dr Andrew Tunks, Executive Chairman of Meteoric Resources (ASX:MEI), provides an update on the company's progress, discussing its transition from gold to rare earths, the advantages of ionic clay over hard rock deposits, and promising early results.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More
